Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Discover which Dividend Etf ranks lowest in fees with a quick fee-focused comparison. Find affordable options and learn how expense ratios affect your returns.
21,760 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
CoreWeave’s stock suffers another long selloff as investors weigh debt exposure against growth in the AI cloud market...
Regulators move toward a sweeping U.S. crypto framework, boosting risk assets and shaping near-term price moves. Bitc...
AST SpaceMobile dropped about 13% in early trading after pricing a $1 billion convertible offering and signaling pote...
The U.S. temporarily eases sanctions on Russian oil loaded on tankers for 30 days, aiming to calm markets amid Middle...
Fidelis Investors closed its fourth rated residential transition loan securitization, a $191.5 million deal backed by...
Anthropic's study identifies which roles are most exposed to AI, warning of wage pressure and hiring shifts as automa...
The ROAD Act was billed as a catalyst for more homes, but builders, lenders, and markets show a tepid path forward as...
The latest quarterly results sparked a sharp drop in MercadoLibre shares. In this guide, we unpack why the stock just...
Bitcoin options totaling about $1.23 billion are set to expire on Friday, July 17, 2026. Analysts expect only a muted...
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
The CLARITY Act moves toward a Senate floor vote, potentially codifying XRP’s regulatory status. This piece breaks do...